← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

AMTX logoAemetis, Inc.(AMTX)Earnings, Financials & Key Ratios

AMTX•NASDAQ
$3.24
$221M mkt cap·Price updated May 6, 2026
SectorEnergyIndustryOil Refining & MarketingSub-IndustryRenewable and Alternative Fuels
AboutAemetis, Inc. operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. It sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. The company also produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. In addition, it produces dairy biogas; produces and sells high-grade alcohol and various feed products, as well as hand sanitizers; and researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.Show more
  • Revenue$208M-22.3%
  • EBITDA-$28M+13.7%
  • Net Income-$77M+12.0%
  • EPS (Diluted)-1.28+33.0%
  • Gross Margin-0.37%-70.4%
  • EBITDA Margin-13.29%-11.0%
  • Operating Margin-17.89%-18.5%
  • Net Margin-37.02%-13.2%
  • ROIC-70.33%-74.6%
  • Interest Coverage-0.61+58.0%
Technical→

AMTX Key Insights

Aemetis, Inc. (AMTX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 96 (top 4%)

✗Weaknesses

  • ✗Profits declining 16.0% over 5 years
  • ✗Negative free cash flow
  • ✗Shares diluted 43.3% in last year

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

AMTX Price & Volume

Aemetis, Inc. (AMTX) stock price & volume — 10-year historical chart

Loading chart...

AMTX Growth Metrics

Aemetis, Inc. (AMTX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years3.56%
5 Years4.67%
3 Years-6.75%
TTM-26.16%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM12.04%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM32.78%

Return on Capital

10 Years-208.92%
5 Years-403.11%
3 Years-652.24%
Last Year-1900.33%

AMTX Recent Earnings

Aemetis, Inc. (AMTX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
Mar 12, 2026
EPS
$0.24
Est $0.27
+11.1%
Revenue
$54M
Est $59M
-9.5%
Q4 2025
Nov 6, 2025
EPS
$0.37
Est $0.25
-48.0%
Revenue
$59M
Est $72M
-17.9%
Q3 2025
Aug 7, 2025
EPS
$0.41
Est $0.35
-17.1%
Revenue
$52M
Est $89M
-41.6%
Q2 2025
May 8, 2025
EPS
$0.47
Est $0.39
-20.5%
Revenue
$43M
Est $91M
-52.9%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 12, 2026
$0.24vs $0.27+11.1%
$54Mvs $59M-9.5%
Q4 2025Nov 6, 2025
$0.37vs $0.25-48.0%
$59Mvs $72M-17.9%
Q3 2025Aug 7, 2025
$0.41vs $0.35-17.1%
$52Mvs $89M-41.6%
Q2 2025May 8, 2025
$0.47vs $0.39-20.5%
$43Mvs $91M-52.9%
Based on last 12 quarters of dataView full earnings history →

AMTX Peer Comparison

Aemetis, Inc. (AMTX) competitors in Renewable and Alternative Fuels — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
GEVO logoGEVOGevo, Inc.Direct Competitor497.05M2.05-14.648.49%0.75%0.25%0.01
REX logoREXREX American Resources CorporationDirect Competitor1.58B48.0229.10-22.91%7.73%7.67%0.03
ALTO logoALTOAlto Ingredients, Inc.Direct Competitor429.75M5.5634.75-4.9%1.45%6%0.40
GPRE logoGPREGreen Plains Inc.Direct Competitor1.19B16.97-9.43-14.93%-5.8%-15.71%0.66
AVA logoAVAAvista CorporationDirect Competitor3.35B40.5817.051.34%9.83%7.25%1.25
BIOX logoBIOXBioceres Crop Solutions Corp.Product Competitor30.61M0.48-0.59-28.3%-16.6%-16.7%0.94
CLNE logoCLNEClean Energy Fuels Corp.Product Competitor491.3M2.24-2.222.16%-52.22%-39.29%0.18
LOOP logoLOOPLoop Industries, Inc.Product Competitor67.67M1.40-4.4270.17%-24.34%-207.55%8.41

Compare AMTX vs Peers

Aemetis, Inc. (AMTX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs GEVO

Most directly comparable listed peer for AMTX.

Scale Benchmark

vs BE

Larger-name benchmark to compare AMTX against a more recognizable public peer.

Peer Set

Compare Top 5

vs GEVO, REX, ALTO, GPRE

AMTX Income Statement

Aemetis, Inc. (AMTX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue150.16M171.53M202M165.56M211.95M256.51M186.72M267.64M207.98M
Revenue Growth %4.89%14.23%17.77%-18.04%28.02%21.03%-27.21%43.34%-22.29%
Cost of Goods Sold146.78M166.12M189.3M154.53M204.01M262.05M184.7M268.22M208.75M
COGS % of Revenue97.75%96.85%93.71%93.34%96.25%102.16%98.92%100.22%100.37%
Gross Profit
3.38M▲ 0%
5.41M▲ 60.1%
12.7M▲ 134.9%
11.03M▼ 13.2%
7.94M▼ 28.0%
-5.54M▼ 169.7%
2.02M▲ 136.4%
-580K▼ 128.8%
-768K▼ 32.4%
Gross Margin %2.25%3.15%6.29%6.66%3.75%-2.16%1.08%-0.22%-0.37%
Gross Profit Growth %-70.9%60.15%134.93%-13.18%-27.99%-169.72%136.44%-128.76%-32.41%
Operating Expenses15.56M16.33M17.63M17.09M23.76M28.87M39.42M39.84M36.45M
OpEx % of Revenue10.36%9.52%8.73%10.33%11.21%11.25%21.11%14.88%17.53%
Selling, General & Admin13.19M16.09M17.42M16.88M23.68M28.69M39.27M39.84M36.45M
SG&A % of Revenue8.78%9.38%8.63%10.2%11.17%11.18%21.03%14.88%17.53%
Research & Development2.37M246K205K213K88K180K152K00
R&D % of Revenue1.58%0.14%0.1%0.13%0.04%0.07%0.08%--
Other Operating Expenses000000000
Operating Income
-12.18M▲ 0%
-10.93M▲ 10.3%
-4.93M▲ 54.9%
-6.07M▼ 23.1%
-15.82M▼ 160.7%
-34.4M▼ 117.4%
-37.4M▼ 8.7%
-40.42M▼ 8.1%
-37.22M▲ 7.9%
Operating Margin %-8.11%-6.37%-2.44%-3.67%-7.47%-13.41%-20.03%-15.1%-17.89%
Operating Income Growth %-1459.92%10.32%54.87%-23.1%-160.71%-117.38%-8.72%-8.06%7.91%
EBITDA-7.17M-6.21M138K-1.13M-10.33M-28.82M-30.4M-32.03M-27.64M
EBITDA Margin %-4.77%-3.62%0.07%-0.68%-4.87%-11.24%-16.28%-11.97%-13.29%
EBITDA Growth %-278.56%13.43%102.22%-917.39%-815.87%-178.97%-5.47%-5.37%13.71%
D&A (Non-Cash Add-back)5.01M4.72M5.07M4.94M5.49M5.58M7M8.39M9.58M
EBIT-17.86M-18.07M-10.33M-10.02M-27.14M-85.3M-41.85M-58.21M-37.22M
Net Interest Income-19.3M-25.73M-28.01M-31.02M-20.14M-21.41M-32.99M-40.16M-61.14M
Interest Income000000000
Interest Expense19.3M18.21M28.01M31.02M20.14M21.41M32.99M40.16M61.14M
Other Income/Expense-19.58M-25.35M-33.41M-31.57M-31.45M-72.3M-62.76M-57.95M-58.53M
Pretax Income
-31.76M▲ 0%
-36.28M▼ 14.2%
-38.35M▼ 5.7%
-37.63M▲ 1.9%
-47.27M▼ 25.6%
-106.7M▼ 125.7%
-100.16M▲ 6.1%
-98.37M▲ 1.8%
-95.75M▲ 2.7%
Pretax Margin %-21.15%-21.15%-18.98%-22.73%-22.3%-41.6%-53.64%-36.75%-46.04%
Income Tax6K7K1.13M-976K-128K1.05M-53.74M-10.83M-18.75M
Effective Tax Rate %-0.02%-0.02%-2.95%2.59%0.27%-0.99%53.65%11.01%19.58%
Net Income
-30.3M▲ 0%
-33.02M▼ 9.0%
-35.72M▼ 8.2%
-36.66M▼ 2.6%
-47.15M▼ 28.6%
-107.76M▼ 128.6%
-46.42M▲ 56.9%
-87.54M▼ 88.6%
-77M▲ 12.0%
Net Margin %-20.18%-19.25%-17.68%-22.14%-22.24%-42.01%-24.86%-32.71%-37.02%
Net Income Growth %-93.79%-8.96%-8.18%-2.64%-28.61%-128.56%56.92%-88.58%12.04%
Net Income (Continuing)-31.77M-36.29M-39.48M-36.66M-47.15M-107.76M-46.42M-87.54M-77M
Discontinued Operations000000000
Minority Interest-1.47M-4.74M0000000
EPS (Diluted)
-1.53▲ 0%
-1.63▼ 6.5%
-1.75▼ 7.4%
-1.74▲ 0.6%
-1.54▲ 11.5%
-3.12▼ 102.6%
-1.22▲ 60.9%
-1.91▼ 56.6%
-1.28▲ 33.0%
EPS Growth %-93.67%-6.54%-7.36%0.57%11.49%-102.6%60.9%-56.56%32.98%
EPS (Basic)-1.53-1.63-1.75-1.74-1.54-3.12-1.22-1.91-1.28
Diluted Shares Outstanding19.83M20.25M20.47M21.01M30.68M34.59M38.06M45.9M65.78M
Basic Shares Outstanding19.8M20.25M20.41M21.01M30.61M34.54M38.06M45.9M65.78M
Dividend Payout Ratio---------

AMTX Balance Sheet

Aemetis, Inc. (AMTX) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets11.46M10.31M12.58M8.68M20.69M18.14M36.4M44.7M26.87M
Cash & Short-Term Investments428K1.19M656K592K7.75M4.31M2.67M898K4.89M
Cash Only428K1.19M656K592K7.75M4.31M2.67M898K4.89M
Short-Term Investments000000000
Accounts Receivable2.22M1.1M2.04M1.82M1.57M1.26M8.63M14.11M484K
Days Sales Outstanding5.392.333.684.012.711.816.8819.240.85
Inventory5.74M6.13M6.52M3.97M5.13M4.66M18.29M25.44M11.63M
Days Inventory Outstanding14.2713.4712.579.379.176.4936.1534.6220.33
Other Current Assets643K956K2.57M1.55M644K3.65M3.46M2.41M9.87M
Total Non-Current Assets82.87M81.51M87.32M116.46M140.14M188.98M207.01M214.61M232.97M
Property, Plant & Equipment78.84M78.49M84.78M112.77M137.56M167.45M181.73M186.2M219.72M
Fixed Asset Turnover1.90x2.19x2.38x1.47x1.54x1.53x1.03x1.44x0.95x
Goodwill000000000
Intangible Assets000000000
Long-Term Investments000000000
Other Non-Current Assets4.03M3.02M2.54M3.69M2.58M21.52M25.27M28.41M13.25M
Total Assets
94.33M▲ 0%
91.82M▼ 2.7%
99.9M▲ 8.8%
125.14M▲ 25.3%
160.83M▲ 28.5%
207.11M▲ 28.8%
243.41M▲ 17.5%
259.3M▲ 6.5%
259.84M▲ 0.2%
Asset Turnover1.59x1.87x2.02x1.32x1.32x1.24x0.77x1.03x0.80x
Asset Growth %21.23%-2.66%8.79%25.27%28.52%28.78%17.52%6.53%0.21%
Total Current Liabilities36.02M42.58M57.82M102.23M65.33M88.28M84.39M143.97M371.26M
Accounts Payable10.46M13.5M15.97M20.74M16.41M26.17M32.13M33.14M23.42M
Days Payables Outstanding2629.6630.7948.9829.3736.4563.545.140.95
Short-Term Debt18.57M20.35M22.74M59.52M22.78M49.22M37.03M90.53M317.87M
Deferred Revenue (Current)6.99M8.73M0000000
Other Current Liabilities3.31M5.4M8.44M9.79M12.85M12.56M14.82M20.3M29.97M
Current Ratio0.32x0.24x0.22x0.08x0.32x0.21x0.43x0.31x0.07x
Quick Ratio0.16x0.10x0.10x0.05x0.24x0.15x0.21x0.13x0.04x
Cash Conversion Cycle-6.34-13.86-14.54-35.6-17.49-28.16-10.488.76-19.77
Total Non-Current Liabilities136.71M154.82M196.45M207.65M215.74M320.69M375.99M379.26M195.41M
Long-Term Debt138.16M164.82M179.69M170.1M165.99M197.02M257.69M247.53M0
Capital Lease Obligations00200K2.58M2.32M2.19M1.78M00
Deferred Tax Liabilities000000000
Other Non-Current Liabilities15K016.56M34.97M47.43M121.48M116.52M131.74M195.41M
Total Liabilities172.72M197.4M254.27M309.88M281.07M408.97M460.38M523.23M566.67M
Total Debt15.63M17.3M203M232.51M191.34M248.77M296.91M338.06M317.87M
Net Debt15.2M16.11M202.35M231.92M183.59M244.45M294.24M337.16M312.98M
Debt / Equity---------
Debt / EBITDA--1471.03x------
Net Debt / EBITDA--1466.28x------
Interest Coverage-0.93x-0.99x-0.37x-0.32x-1.35x-3.98x-1.27x-1.45x-0.61x
Total Equity
-79.86M▲ 0%
-105.58M▼ 32.2%
-154.37M▼ 46.2%
-184.74M▼ 19.7%
-120.24M▲ 34.9%
-201.85M▼ 67.9%
-216.98M▼ 7.5%
-263.93M▼ 21.6%
-306.83M▼ 16.3%
Equity Growth %-60.32%-32.21%-46.21%-19.67%34.92%-67.88%-7.49%-21.64%-16.26%
Book Value per Share-4.03-5.21-7.54-8.79-3.92-5.84-5.70-5.75-4.66
Total Shareholders' Equity-78.39M-100.84M-154.37M-184.74M-120.24M-201.85M-216.98M-263.93M-306.83M
Common Stock20K20K21K23K33K36K41K51K66K
Retained Earnings-160.19M-193.2M-237.42M-274.08M-321.23M-428.99M-475.4M-562.94M-639.94M
Treasury Stock000000000
Accumulated OCI-2.9M-3.58M-3.83M-4.11M-4.35M-5.45M-5.67M-6.37M-7.36M
Minority Interest-1.47M-4.74M0000000

AMTX Cash Flow Statement

Aemetis, Inc. (AMTX) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations-8.69M-5.51M-2.03M2.48M-20.65M-22.87M13.82M-32.93M3.26M
Operating CF Margin %-5.79%-3.21%-1.01%1.5%-9.74%-8.91%7.4%-12.3%1.57%
Operating CF Growth %-2441.78%36.63%63.06%221.93%-932.54%-10.75%160.46%-338.18%109.91%
Net Income-31.77M-36.29M-39.48M-36.66M-47.15M-107.76M-46.42M-87.54M-77M
Depreciation & Amortization5.01M4.72M4.48M4.94M5.49M5.58M7M8.39M9.63M
Stock-Based Compensation1.1M836K694K995K3.93M6.41M7.66M8.31M5.77M
Deferred Taxes5.4M874K1.12M-984K0832K-750K00
Other Non-Cash Items118K7.59M6.92M9.33M11.69M66.02M32.25M22.7M14.55M
Working Capital Changes11.45M16.77M24.22M24.85M5.39M6.05M14.08M15.21M50.32M
Change in Receivables-1.01M1.08M-963K-1.09M94K294K-7.42M-5.55M13.6M
Change in Inventory-2.37M-721K-491K2.39M-2.21M360K-13.84M-7.77M13.12M
Change in Payables2.58M2.21M1M1.4M-5.2M2.18M13.73M-1.29M-7.53M
Cash from Investing-1.12M-4.07M-8.58M-17.31M-22.89M-31.31M-23.69M-14.15M-25.59M
Capital Expenditures-1.12M-4.07M-8.58M-19.34M-26.65M-39.16M-33.12M-20.25M-26M
CapEx % of Revenue0.74%2.38%4.25%11.68%12.57%15.27%17.74%7.57%12.5%
Acquisitions000000000
Investments---------
Other Investing0002.03M3.76M7.85M9.43M6.11M411K
Cash from Financing8.38M10.39M10.09M14.78M50.7M53.63M9.09M44.62M26.41M
Debt Issued (Net)8.38M3.43M4.44M-4.29M-56.03M42.61M18.92M14.27M7.65M
Equity Issued (Net)004.82M18.87M106.42M11.99M-8.28M31.75M28.33M
Dividends Paid000000000
Share Repurchases451K00000000
Other Financing06.96M834K193K311K-963K-1.55M-1.41M-9.58M
Net Change in Cash
-1.06M▲ 0%
760K▲ 171.8%
-532K▼ 170.0%
-64K▲ 88.0%
7.16M▲ 11285.9%
-752K▼ 110.5%
-719K▲ 4.4%
-2.45M▼ 240.6%
4.05M▲ 265.6%
Free Cash Flow
-9.8M▲ 0%
-9.58M▲ 2.3%
-10.61M▼ 10.8%
-16.86M▼ 58.9%
-47.3M▼ 180.5%
-62.02M▼ 31.1%
-19.29M▲ 68.9%
-53.18M▼ 175.6%
-22.74M▲ 57.2%
FCF Margin %-6.53%-5.59%-5.25%-10.18%-22.32%-24.18%-10.33%-19.87%-10.93%
FCF Growth %-3700%2.28%-10.77%-58.88%-180.54%-31.13%68.89%-175.65%57.24%
FCF per Share-0.49-0.47-0.52-0.80-1.54-1.79-0.51-1.16-0.35
FCF Conversion (FCF/Net Income)0.29x0.17x0.06x-0.07x0.44x0.21x-0.30x0.38x-0.04x
Interest Paid3.09M5.59M2.48M1.32M5.68M19.52M9.81M9.22M0
Taxes Paid6K6K8K8K7K10K20K1.81M0

AMTX Key Ratios

Aemetis, Inc. (AMTX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Invested Capital (ROIC)----7.71%-9.57%-21.48%-48.7%-46.8%-40.28%-70.33%
Gross Margin8.1%2.25%3.15%6.29%6.66%3.75%-2.16%1.08%-0.22%-0.37%
Net Margin-10.92%-20.18%-19.25%-17.68%-22.14%-22.24%-42.01%-24.86%-32.71%-37.02%
Interest Coverage0.09x-0.93x-0.99x-0.37x-0.32x-1.35x-3.98x-1.27x-1.45x-0.61x
FCF Conversion-0.02x0.29x0.17x0.06x-0.07x0.44x0.21x-0.30x0.38x-0.04x
Revenue Growth-2.38%4.89%14.23%17.77%-18.04%28.02%21.03%-27.21%43.34%-22.29%

AMTX SEC Filings & Documents

Aemetis, Inc. (AMTX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 16, 2026·SEC

Material company update

Mar 12, 2026·SEC

Material company update

Feb 19, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 16, 2026·SEC

FY 2025

Mar 14, 2025·SEC

FY 2024

Mar 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 7, 2025·SEC

FY 2025

May 8, 2025·SEC

AMTX Frequently Asked Questions

Aemetis, Inc. (AMTX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Aemetis, Inc. (AMTX) reported $197.6M in revenue for fiscal year 2025.

Aemetis, Inc. (AMTX) saw revenue decline by 22.3% over the past year.

Aemetis, Inc. (AMTX) reported a net loss of $77.0M for fiscal year 2025.

Dividend & Returns

Aemetis, Inc. (AMTX) had negative free cash flow of $22.7M in fiscal year 2025, likely due to heavy capital investments.

Explore More AMTX

Aemetis, Inc. (AMTX) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.